Sikander Ailawadhi

Sikander Ailawadhi, MD, a Mayo Clinic myeloma researcher, and Beth Faiman, CNP, PhD, a Cleveland Clinic hematology practitioner, talk about subcutaneous isatuximab delivered via an on-body injector. They cover trial design showing noninferior efficacy to IV, practical advantages like hands-free delivery and fewer reactions, body-weight considerations, home administration pilots, and implications for patient access and convenience.